Innovation Bioengineering
What make us different
Bone-marrow realism - not plastic. MYLeukaemia combines 3D culture, stromal co-culture, perfusable microvessels and controlled gradients to model selected features of the human bone-marrow environment.
Our research hypothesis is that a more human-relevant context can reveal functional-response patterns and microenvironmental effects that simpler models may miss.
Conventional 2D cultures simplify biology, while many 3D models lack marrow-specific perfusion and niche cues. MYLeukaemia is designed to combine biological context with a streamlined research workflow.
Interested in our approach? Contact us to explore a research partnership.
Our trusted partners & supporters
Our Project
Built on two years of FCT-supported research at i3S in Porto, our marrow-avatar platform has progressed from scientific concept to an R&D-stage prototype.
MYCancer is now seeking hospital, reference-laboratory and pharma partners for co-funded R&D, platform validation and prospective research studies.
MRD-ON-CHIP
Fundação para a Ciência e Technologia (FCT)
(2023-2025)
MYCANCER MADEIRA ORIGINS
PRR Re-industrializar- NextGenerationEU
(2026-2028)
Our Publications
Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression
In situ crosslinkable multi-functional and cell-responsive alginate 3D matrix via thiol-maleimide click chemistry
Int J Mol Sci. 2024 Apr 17;25(8):4430.
Carbohydr Polym. 2024 Aug 1:337:122144.
Advancing Organ-on-Chip Models With a Sacrificial Granular Hydrogel Strategy for Enhanced Permeability and Biomimicry
Small Methods. 2025 Nov 5:e00652.
MYCancer. All rights reserved. © 2026
Subscribe to our newsletter
No Spam. Just occasional product updates & events.
Company
About
Careers
News & Press
Contact
Campus da Penteada, 9020-105 Funchal, Portugal ·
How to Join Us:
Start a Pilot
Request Study Design
Request Data Room
For Research Use Only. MYLeukaemia is an R&D-stage bone-marrow-on-chip platform. It is not CE-marked as an in vitro diagnostic medical device and is not intended for diagnosis, clinical assessment, patient management or treatment selection. Any future clinical use is subject to analytical and clinical validation and the applicable regulatory conformity route.
